The genomic research and medical advancements behind precision medicine are crucial to personalizing patient care, but researchers argue that those innovations will have little impact without a concurrent focus on delivery.
A “Precision Delivery Initiative” would complement President Barack Obama’s Precision Medicine Initiative (PMI) by integrating predictive analytics into clinical workflows, tapping into innovative data sources to establish clinically validated best practices and empowering patients to use their own data to support personalized medicine, researchers at Brigham and Women’s Hospital and the University of Pennsylvania wrote in the New England Journal of Medicine.
